Erin Parry, MD PhD
@ErinMParry
Followers
213
Following
201
Media
0
Statuses
24
Physician-scientist, Lymphoma oncologist @DanaFarber | Tweets are my own and not medical advice. #Lymphoma
Boston, MA
Joined October 2019
RT @RomainGuieze: Happy to share the results of our first #richter trial now published @NatureComms .
0
5
0
RT @LiliWangLab: Excited to share our latest publication from the Lili Wang lab! by Prajish Iyer et al.🌟 MGA deletion drives Richter’s tra….
science.org
A MGA/NME1 regulatory axis can promote CLL-to-RT transition by modulating OXPHOS, highlighting this pathway as a target for RT treatment.
0
5
0
RT @AACR: #AACRlymph24 cochair Ari M. Melnick, Sandrine Roulland, and Erin M. Parry discussed "Lymphoma Clonal Precursors and Transformatio….
0
2
0
RT @ASH_hematology: 🔬Are you an early-career researcher ready to take the next step in your research career? Apply for ASH & @EHA_Hematolog….
0
13
0
RT @Lachelle_Dawn: #ASH23 is about running from a meeting in the Marriot all the way to room 28 in the conference center to see @beckyzon r….
0
2
0
RT @DanaFarberNews: At #ASH23, Reid Merryman, MD @DanaFarber reveals results from a pilot study that uses circulating tumor DNA to reliably….
0
3
0
RT @RemyDulery: #ASH23 - Abstract 223.Outstanding presentation by @Dr_KatieM 👏🏻👏🏻👏🏻. Response to axi-cel is associated with:.✅The presence….
0
4
0
RT @DrMDavids: @inhyeahn from @DanaFarber presenting at #iwcll2023 on one of the largest datasets ever reported for BTKi resistance mec….
0
4
0
RT @iwCLL: Congratulations to Dr. Susan O’Brien (@UCIrvineHealth) and Dr. Catherine Wu (@DanaFaber), recipients of the iwCLL Binet-Rai Meda….
0
20
0
Had a great time at #iwCLL2023 sharing our work @RomainGuieze @lesh_lab @getz_lab Stilgenbauer and Wu in an amazing genomics session! Fascinating talks by Cindy Hahn @FerranNadeu @PaulineRobbe.
@iwCLL2023 So many great contributions to the #Richter biology this year ! Bravo to @ErinMParry and @FerranNadeu for such great talks !
0
1
15
Congrats Elisa!.
#AndJustLikeThat 🌟the ten Hacken lab is officially live from @WeillCornell NYC! 🌟. Join me in this new exciting adventure if you are interested in understanding chronic lymphocytic leukemia and Richter’s syndrome through mouse modeling (and more!). Recruiting at all levels!.
0
0
2
RT @DanaFarber: The story behind Venetoclax, a new cancer therapy, started nearly 40 years ago. How it went from the discovery of a protein….
podcasts.apple.com
Podcast Episode · Unraveled · 02/01/2023 · 30m
0
3
0
RT @DanaFarberNews: During an early morning session here at #ASH22, there’s an overflow crowd for @DanaFarber Caron Jacobson’s, MD, MMSc, p….
0
5
0
RT @ChristineRyanMD: This was all only possible because of the study’s lead investigator and my incredible mentor @DrMDavids. Many, many th….
0
2
0
RT @BCD_AACR: In vivo modeling of #CLL transformation to #Richtersyndrome reveals convergent evolutionary paths and therapeutic vulnerabili….
0
5
0
RT @etenhacken: 1/Very excited to see this out online at @BCD_AACR!. Check out our novel mouse models reflective of chronic lymphocytic leu….
0
15
0
RT @livius_tacitus: @etenhacken has developed a new model for Richter's syndrome, the transition of #CLL to a high-grade lymphoma, which is….
0
1
0
RT @livius_tacitus: Finally, we also saw mtDNA mutations that were further enriched in the Richter's model after transplant into a recipien….
0
1
0
RT @livius_tacitus: 🐭 Can mitochondrial DNA mutations track lineage in murine cancer models❓ Together w/ @etenhacken plus the mtDNA experts….
0
25
0